tert-butyl (1R,4R)-5-[4-(4-{[(4-acetylphenyl)carbamoyl]amino}phenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate | 1197162-99-4

• 英文名称: tert-butyl (1R,4R)-5-[4-(4-{[(4-acetylphenyl)carbamoyl]amino}phenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
• 英文别名: tert-butyl (1R,4R)-5-[4-[4-[(4-acetylphenyl)carbamoylamino]phenyl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
• CAS: 1197162-99-4
• 化学式: C₃₂H₃₈N₈O₅
• 分子量: 614.704
• InChiKey: IKQUOHFVFTWOMP-CLJLJLNGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  45
• 可旋转键数：
  8
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  142
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS
  申请人：WYETH LLC

  公开号：US20150011752A1

  公开（公告）日：2015-01-08

  Compounds of formula I wherein: R 1 is and R 2 , R 4 , and R 6-9 are defined herein, and pharmaceutically acceptable salts and esters thereof. These compounds inhibit PI3 kinase and mTOR, and may be used to treat diseases mediated by PI3 kinase and mTOR, such as a variety of cancers. Methods for making and using the compounds of this invention are disclosed. Various compositions containing the compounds of this invention are also disclosed.

  公式I的化合物，其中：R1是，R2，R4和R6-9在此定义，并且其药学上可接受的盐和酯。这些化合物抑制PI3激酶和mTOR，并且可用于治疗由PI3激酶和mTOR介导的疾病，例如多种癌症。本发明揭示了制备和使用这些化合物的方法。还揭示了包含本发明化合物的各种组合物。
• TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS
  申请人：Wyeth LLC

  公开号：EP2300483A1

  公开（公告）日：2011-03-30
• US8039469B2
  申请人：——

  公开号：US8039469B2

  公开（公告）日：2011-10-18
• US9174963B2
  申请人：——

  公开号：US9174963B2

  公开（公告）日：2015-11-03